IInnddiiaa AHdohsepsiitvael sMMaar rkkeet t orreeccaasstt & &O Op pp po orrttu un niittiiee s , 2 20 02 20 0 FFo r kae t& I H n et ea l lt ihgceanrcee C. oCnos nu sl tual n t itns g P hMa ar m
Industry Brief Indi In dia a Ho Hosp spit ital al Ma Mark rket et to Cr Cros oss s US US$1 $189 89 Bi Bill llio ion n by 20 2020 20 Rising incidence of diseases, expanding middle class population and increasing awareness regarding preventive care is driving India hospital market According to Pharmaion report “India Ho Hosp spit ital al Ma Mark rket et Fo Fore reca cast st & Op Oppo port rtun unit itie ies, s, 20 2020 20”, India hospital market is forecast to cross US$ 189 billion by 2020.Increasing income levels of the middle class population, and preference for high quality healthcare services offered by private hospitals; demographic demographi c transition; changing consumer lifestyle; and increasing incidence of non-communicab non-communicable le diseases, chronic and non-chronic diseases is fueling growth in India hospital market. Additionally, rising penetration of health insurance schemes is further propelling growth in India hospital market. In terms of ownership, private sector in India dominates the country’s hospital market. Over the course of next five years, domestic as well as foreign private sector investments would be required in order to pump revenue growth in India hospital market and meet the demand for high quality healthcare services in the country. Availability of high quality healthcare services at cheaper costs compared to developed countries is boosting growth in medical tourism, thereby driving hospital market in the country. Growing medical tourism in India is encouraging healthcare providers to maintain international standards in their facilities, and thereby offer healthcare service at par with developed countries. “Emergence of advanced technologies such as telemedicine, cloud computing and growing popularity of day care surgery in India is projected to drive growth in India hospital market over the next five years. Accessibility to healthcare services for rural population can be improved with the use of cloud comput com puting ing tec techno hnolog logies ies,, whi which ch not onl only y inc increa reases ses acce accessi ssibil bility ity of pat patien ientt dat data a acr across oss va vario rious us geographies, but also reduces delays in diagnosis and treatment by healthcare providers. Increasing elderly population and lack of adequate number of healthcare professionals in hospitals is expected to pump growth in demand for telemedicine services from hospitals, thereby enabling better access to healthcare services in the country.”, said Mr. Karan Chechi, Research Director with Pharmaion, a research based global management consulting firm.
2
Ta b l e o f C o n t e n t s S. No.
Contents
1.
Research Me Methodology
2.
Analyst View
3.
Hospital Overview
4.
Global Ho Hospital Ma Market Ov Overview
5.
India Hospital Market Outlook 5.1 .1..
5.2. 5. 2.
6.
Mark Ma rke et Si Size ze & Fo Fore rec cas astt 5.1.1.
By Valu lue e
5.1 5. 1.2 .2..
By Vol olum ume e
Mark Ma rket et Sh Shar are e & Fo Fore reca cast st 5.2 5. 2.1 .1..
By Re Regi gion on
5.2 5. 2.2 .2..
By Com ompa pany ny
5.2.1. 5.2 .1.
By Own Owners ership hip (Go (Gover vernmen nment, t, Pri Privat vate, e, Oth Others ers))
5.2. 5. 2.2. 2.
By Re Reac ach h (Ru (Rura ral, l, Ur Urba ban) n)
5.2.3.
By Clinical Care (Multispecialty, General, Single speciality, Others)
Indi In dia a Mu Mult ltis ispe peci cial alty ty Hos Hospi pita tall Mark Market et Out Outlo look ok 6.1 .1..
Mark Ma rke et Si Size ze & Fo Fore rec cas astt 6.1.1.
6.2. 6. 2.
By Valu lue e
Mark Ma rket et Sh Shar are e & Fo Fore reca cast st 6.2.1.
By Reach
6.2. 6. 2.2. 2.
By Ow Owne ners rshi hip p
3
Ta b l e o f C o n t e n t s S. No.
Contents 7.1. 7. 1.
Mark Ma rket et Si Size ze & Fo Fore reca cast st 7.1.1.
7.2. 7. 2.
8.
Mark Ma rket et Sh Shar are e & Fo Fore reca cast st 7.2.1.
By Reach
7.2.2
By Ownership
Ind In dia Si Sing ngle le Spe Speci cial alty ty Ho Hosp spit ita al Ma Mark rket et Out Outlo loo ok 8.1. 8. 1.
Mark Ma rket et Si Size ze & Fo Fore reca cast st 8.1.1.
8.2. 8. 2.
9.
By Value
By Value
Mark Ma rket et Sh Shar are e & Fo Fore reca cast st 8.2 .2..1.
By Sp Spec ecia iali liza zati tio on
8.2.2.
By Reach
8.2.3.
By Owne nerrshi hip p
India Hospital Industry Space Analysis
10.. 10
Indi In dia a Ho Hosp spit ital al Valu lue e Cha Chain in An Ana aly lys sis
11.. 11
Indi In dia a Hos Hospi pita tall Inv Inves estm tmen entt La Land ndsc sca ape
12.
Market Dynamics
13.
12.1.1
Drivers
12.1 12 .1.2 .2..
Chal Ch alle leng nge es
Mar Ma rket Tren end ds & Devel elo opmen ents ts 13.1. 13. 1.
Increa Inc reasing sing Ado Adoptio ption n of Day Car Care e Sur Surger gery y
4
Ta b l e o f C o n t e n t s S. No.
Contents 13.3 13 .3..
Grow Gr owin ing g Po Popu pula lari rity ty of Te Tele leme medi dici cine ne Se Serv rvic ices es
13.4.
India – A Popular Medical Tourism Destination
13.5. 13. 5.
Increa Inc reasing sing Num Number ber of Publ Public ic Pri Privat vate e Par Partner tnership ships s for Hos Hospita pitals ls
14.
Policy & Regulatory La Landscape
15.
India Ec Economic Pr Profile
16.
Competitive L an andscape 16.1 16 .1..
16.2.
Comp Co mpet etiti ition on Be Bench nchma mark rking ing (M (Mar arke kett At Attr trac activ tivene eness ss)) 16.1 16 .1.1 .1..
By Af Affo ford rdab abili ility ty
16.1 16 .1.2 .2..
By Ac Acce cess ssibi ibilit lity y
Company Profiles
16.2 16 .2.1 .1..
Fort Fo rtis is He Healt althc hcar are e Lim Limit ited ed
16.2 16 .2.2 .2..
Apoll Ap ollo o Ho Hosp spita itals ls Ent Enter erpr pris ises es
16.2 16 .2.3 .3..
Nara Na raya yana na Hea ealt lth h
16.2 16 .2.4 .4..
Mani Ma nipa pall Ho Hosp spit ital als s
16.2.5 16. 2.5..
All Indi India a Ins Instit titute ute of Med Medica icall Sci Scienc ences es
16.2.6 16. 2.6..
Postt Gra Pos Gradua duate te Ins Instit titute ute of Med Medica icall Educ Educati ation on & Res Resear earch ch (PG (PGIME IMER) R)
16.2 16 .2..7.
CAR CA RE Hospit ita als
16.2 16 .2.8 .8..
Max Ma x He Healt althc hcar are e In Inst stitu itute te Lim Limite ited d
16.2 16 .2.9 .9..
Wock Wo ckha hard rdtt Ho Hosp spit ital al Pv Pvt. t. Lt Ltd. d.
16.2 16 .2.1 .10. 0.
Meda Me danta nta-- The Me Medic dicity ity
17.
Strategic Recommendations
18
About Us & Disclaimer
5
Research Methodology Baseli Bas eline ne Met Method hodolo ology gy :
For the study, Pharmaion has gathered information through primary research with respondents in Hospital Industry across India, followed by external validation of the information by interviewing hospital administrators. We also gathere gathered d insights through an exhaust exhaustive ive search of credible paid databases databases and our internal database. Our tea team m of ana analys lysts ts has prudently prudently eva evaluat luated ed all the collected collected informati information on and pre present sented ed the sam same e in chronological order to depict a meaningful and clear picture of hospital market in India.
While compiling the data, we have also validated all the collected information from multiple sources and data warehouses, in order to present the most accurate and precise information of the concerned industry. The informa info rmatio tion n has then bee been n ver verifie ified d thro through ugh prim primary ary research research sur survey veys s wit with h com competi petitor tors s to arr arrive ive at logi logical cal figures.
Hospit Hos pitals als In Inter tervie viewed wed Apollo Hospitals, Fortis Healthcare, Max Healthcare, Narayan Health, CARE Hospital, Medanta Medicity, Wockhardt Hospitals
Sour So urce ces s: Company Compa ny Website Websites, s, Company Annual Reports, Government database (NSSO, Government of India Planning Commission, Ministry of Commerce & Industry), WHO reports
6
S a m pl e Da t a - S n ap s h ot India Hospital Market Size, By Volume, 20102020F (Number of Beds in Millions) 10
9
8
12
11
13
India Hospital Market share, By Ownership, By
Share, By Company, By
Volume (Number of Beds), 2014
Volume (Number of Beds), 2020F
6 3
4
India Private Hospital Market
5
Fortis Healthca re
15.00%
2
34.00%
33.00%
20.00% 15.00%
2010 2010 2011 2011 2012 2012 2013 2013 2014 2014
2015E2016 2015E2016FF 2017F2018 2017F2018FF 2019F2020 2019F2020FF 33.00%
15.00%
India Hospital Bed Density, By State, 2014 (Number of Beds Per Thousand People)
1
2
3
4
5
6
7
8
9
10
11
15.00% 12
13
Private Private Hospital Hospital
Governeme Governement nt Hospital Hospital
1…
Others Others
(Number of beds), 2010-2020F 34.00% 34.01% 34.02% 34.03% 34.04% 34.05% 34.06% 34.07% 34.08% 34.09% 34.10%
Lo
Medium
High
OWNERSHIP STRUCTURE, March 2015
24.00% 24.01% 24.02% 24.03% 24.04% 24.05% 24.06% 24.07% 24.08% 24.09% 24.10%
21.00% 20.00% 20.10% 20.20% 20.30% 20.40% 20.50% 20.60% 20.70% 20.80% 20.90% 18.00% 18.01% 18.01% 18.02% 18.02% 18.03% 18.03% 18.04% 18.04% 18.05% 18.05% 18.06% 18.06% 18.07% 18.07% 18.08% 18.08% 18.09% 18.09% 18.10% 18.10%
Public shareholding, X%
Narayan a Health
List of Some Hospital Projects by State or Central Government
Market Attractiveness
India Hospital Market Share, By Region, By Volume
Apollo Hospital s
Promote r and Promote r Group,…
Project
Place
X
Kerala
X
Sannidh anam, Kerala Mysore
X
X
Karnatak a
X
X
Waranga l, Andhra Pradesh
X
X
Tamil Nadu
X
X
Project Estimat ed cost X
X
7
Report Ordering
Report Name: India Hospital Market Forecast and Opportunities, 2020
Report Price License Type
Price
Single User License
$2500
Single User License Print
$3000
Enterprise License
$5000
To View Sample OR Purchase Report
8
A b o u t U s & D i s c l a i m e r About Us Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. industry. Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advis advisory ory servi services ces that help them ident identify ify new market opportuniti opportunities, es, growth engines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Pharmaion Pharmaio n is com committ mitted ed to assi assistin sting g cust customers omers worldwide worldwide with their uniq unique ue mark market et rese research arch needs by prov providin iding g them with comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advise and assist customers in meeting their full service market research and consulting requirements.
Relate Rel ated d Rep Report orts s India Stem Cell Market Forecast & Opportunities, 2020 Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020 Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020
Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable reliable and first hand. However, Pharmaion Pharmaion Consultants does not guarantee the accuracy, accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants. Consultants.
NORTH AMERICA Pharmaion Consultants LLC 708 3RD Avenue, 6th Floor, New York, NY, United States, 10017
[email protected] +1 646 360 1656
ASIA-PACIFIC Pharmaion Consultants Pvt. Ltd. A – 51, Sector 57, Noida, National Capital Region, India Indi a - 201 201301 301
[email protected] +91 - 120 - 452 390 3900 0
9
